vs

Side-by-side financial comparison of Astrana Health, Inc. (ASTH) and SERVICE CORP INTERNATIONAL (SCI). Click either name above to swap in a different company.

SERVICE CORP INTERNATIONAL is the larger business by last-quarter revenue ($1.1B vs $950.5M, roughly 1.2× Astrana Health, Inc.). SERVICE CORP INTERNATIONAL runs the higher net margin — 14.3% vs 0.7%, a 13.6% gap on every dollar of revenue. On growth, Astrana Health, Inc. posted the faster year-over-year revenue change (42.9% vs 1.7%). SERVICE CORP INTERNATIONAL produced more free cash flow last quarter ($87.2M vs $-6.0M). Over the past eight quarters, Astrana Health, Inc.'s revenue compounded faster (53.3% CAGR vs 3.1%).

Astrana Health, Inc. is a U.S.-based value-based healthcare services provider that primarily serves Medicare-eligible senior populations across the United States. It offers in-home primary care, chronic disease management, and care coordination services, aiming to improve patient health outcomes and reduce unnecessary medical costs.

International Distribution Services Limited is a British company providing postal and courier services. IDS was created in 2013 by the UK government as a new holding company of Royal Mail, and a majority of its shares were then sold on the London Stock Exchange, with the government initially retaining a 30 per cent at the time. As of April 2025, IDS is owned and operated by Czech-based EP Group, owned by Daniel Křetínský.

ASTH vs SCI — Head-to-Head

Bigger by revenue
SCI
SCI
1.2× larger
SCI
$1.1B
$950.5M
ASTH
Growing faster (revenue YoY)
ASTH
ASTH
+41.2% gap
ASTH
42.9%
1.7%
SCI
Higher net margin
SCI
SCI
13.6% more per $
SCI
14.3%
0.7%
ASTH
More free cash flow
SCI
SCI
$93.2M more FCF
SCI
$87.2M
$-6.0M
ASTH
Faster 2-yr revenue CAGR
ASTH
ASTH
Annualised
ASTH
53.3%
3.1%
SCI

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ASTH
ASTH
SCI
SCI
Revenue
$950.5M
$1.1B
Net Profit
$6.6M
$159.4M
Gross Margin
28.0%
Operating Margin
1.9%
24.8%
Net Margin
0.7%
14.3%
Revenue YoY
42.9%
1.7%
Net Profit YoY
184.4%
5.3%
EPS (diluted)
$0.12
$1.13

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ASTH
ASTH
SCI
SCI
Q4 25
$950.5M
$1.1B
Q3 25
$956.0M
$1.1B
Q2 25
$654.8M
$1.1B
Q1 25
$620.4M
$1.1B
Q4 24
$665.2M
$1.1B
Q3 24
$478.7M
$1.0B
Q2 24
$486.3M
$1.0B
Q1 24
$404.4M
$1.0B
Net Profit
ASTH
ASTH
SCI
SCI
Q4 25
$6.6M
$159.4M
Q3 25
$373.0K
$117.5M
Q2 25
$9.4M
$122.9M
Q1 25
$6.7M
$142.9M
Q4 24
$-7.8M
$151.4M
Q3 24
$16.1M
$117.8M
Q2 24
$19.2M
$118.2M
Q1 24
$14.8M
$131.3M
Gross Margin
ASTH
ASTH
SCI
SCI
Q4 25
28.0%
Q3 25
25.1%
Q2 25
25.5%
Q1 25
27.1%
Q4 24
28.0%
Q3 24
24.9%
Q2 24
24.9%
Q1 24
26.2%
Operating Margin
ASTH
ASTH
SCI
SCI
Q4 25
1.9%
24.8%
Q3 25
2.0%
21.4%
Q2 25
3.1%
21.1%
Q1 25
3.3%
23.4%
Q4 24
0.1%
24.0%
Q3 24
5.9%
20.9%
Q2 24
6.2%
21.4%
Q1 24
7.5%
22.2%
Net Margin
ASTH
ASTH
SCI
SCI
Q4 25
0.7%
14.3%
Q3 25
0.0%
11.1%
Q2 25
1.4%
11.5%
Q1 25
1.1%
13.3%
Q4 24
-1.2%
13.8%
Q3 24
3.4%
11.6%
Q2 24
3.9%
11.4%
Q1 24
3.7%
12.6%
EPS (diluted)
ASTH
ASTH
SCI
SCI
Q4 25
$0.12
$1.13
Q3 25
$0.01
$0.83
Q2 25
$0.19
$0.86
Q1 25
$0.14
$0.98
Q4 24
$-0.14
$1.02
Q3 24
$0.33
$0.81
Q2 24
$0.40
$0.81
Q1 24
$0.31
$0.89

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ASTH
ASTH
SCI
SCI
Cash + ST InvestmentsLiquidity on hand
$429.5M
$243.6M
Total DebtLower is stronger
$5.1B
Stockholders' EquityBook value
$779.3M
$1.6B
Total Assets
$2.2B
$18.7B
Debt / EquityLower = less leverage
3.10×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ASTH
ASTH
SCI
SCI
Q4 25
$429.5M
$243.6M
Q3 25
$463.4M
$241.3M
Q2 25
$342.1M
$255.4M
Q1 25
$260.9M
$227.2M
Q4 24
$290.8M
$218.8M
Q3 24
$350.3M
$185.4M
Q2 24
$327.7M
$184.4M
Q1 24
$337.3M
$205.6M
Total Debt
ASTH
ASTH
SCI
SCI
Q4 25
$5.1B
Q3 25
$5.0B
Q2 25
$5.0B
Q1 25
$4.7B
Q4 24
$4.8B
Q3 24
$4.7B
Q2 24
$4.7B
Q1 24
$4.6B
Stockholders' Equity
ASTH
ASTH
SCI
SCI
Q4 25
$779.3M
$1.6B
Q3 25
$775.5M
$1.6B
Q2 25
$765.5M
$1.6B
Q1 25
$745.4M
$1.7B
Q4 24
$712.7M
$1.7B
Q3 24
$704.6M
$1.6B
Q2 24
$678.9M
$1.5B
Q1 24
$653.5M
$1.6B
Total Assets
ASTH
ASTH
SCI
SCI
Q4 25
$2.2B
$18.7B
Q3 25
$2.2B
$18.4B
Q2 25
$1.4B
$18.0B
Q1 25
$1.3B
$17.3B
Q4 24
$1.4B
$17.4B
Q3 24
$1.3B
$17.4B
Q2 24
$1.3B
$16.8B
Q1 24
$1.2B
$16.7B
Debt / Equity
ASTH
ASTH
SCI
SCI
Q4 25
3.10×
Q3 25
3.17×
Q2 25
3.19×
Q1 25
2.87×
Q4 24
2.83×
Q3 24
2.92×
Q2 24
3.05×
Q1 24
2.90×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ASTH
ASTH
SCI
SCI
Operating Cash FlowLast quarter
$-2.9M
$212.9M
Free Cash FlowOCF − Capex
$-6.0M
$87.2M
FCF MarginFCF / Revenue
-0.6%
7.8%
Capex IntensityCapex / Revenue
0.3%
11.3%
Cash ConversionOCF / Net Profit
-0.44×
1.34×
TTM Free Cash FlowTrailing 4 quarters
$104.5M
$554.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ASTH
ASTH
SCI
SCI
Q4 25
$-2.9M
$212.9M
Q3 25
$10.0M
$252.3M
Q2 25
$90.9M
$166.4M
Q1 25
$16.6M
$311.1M
Q4 24
$-10.9M
$264.1M
Q3 24
$34.0M
$263.8M
Q2 24
$23.2M
$196.9M
Q1 24
$6.0M
$220.1M
Free Cash Flow
ASTH
ASTH
SCI
SCI
Q4 25
$-6.0M
$87.2M
Q3 25
$7.4M
$150.7M
Q2 25
$89.5M
$83.4M
Q1 25
$13.6M
$233.0M
Q4 24
$-13.5M
$151.8M
Q3 24
$31.7M
$162.8M
Q2 24
$20.4M
$100.8M
Q1 24
$5.6M
$140.3M
FCF Margin
ASTH
ASTH
SCI
SCI
Q4 25
-0.6%
7.8%
Q3 25
0.8%
14.2%
Q2 25
13.7%
7.8%
Q1 25
2.2%
21.7%
Q4 24
-2.0%
13.9%
Q3 24
6.6%
16.1%
Q2 24
4.2%
9.7%
Q1 24
1.4%
13.4%
Capex Intensity
ASTH
ASTH
SCI
SCI
Q4 25
0.3%
11.3%
Q3 25
0.3%
9.6%
Q2 25
0.2%
7.8%
Q1 25
0.5%
7.3%
Q4 24
0.4%
10.3%
Q3 24
0.5%
10.0%
Q2 24
0.6%
9.3%
Q1 24
0.1%
7.6%
Cash Conversion
ASTH
ASTH
SCI
SCI
Q4 25
-0.44×
1.34×
Q3 25
26.69×
2.15×
Q2 25
9.65×
1.35×
Q1 25
2.48×
2.18×
Q4 24
1.75×
Q3 24
2.11×
2.24×
Q2 24
1.21×
1.67×
Q1 24
0.40×
1.68×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ASTH
ASTH

Medicare$542.4M57%
Commercial$99.1M10%
Care Delivery$92.1M10%
Care Enablement$78.9M8%
Other Third Parties$58.0M6%
Health Care Patient Service$39.8M4%
Health Care Other$25.5M3%
Other$12.1M1%
Management Service$10.3M1%

SCI
SCI

Cemetery$510.9M46%
Funeral Matured Preneed Revenue$196.5M18%
Cemetery Recognized Preneed Merchandise And Service Revenue$107.4M10%
Cemetery Atneed Revenue$104.9M9%
CA$56.4M5%
Funeral Other Revenue$54.6M5%
Cemetery Other Revenue$40.2M4%
Nonfuneral Home Revenue$28.1M3%
Non Funeral Home Preneed Sales Revenue$22.0M2%

Related Comparisons